Literature DB >> 19152835

Prediction of drug distribution within blood.

Paulo Paixão1, Luís F Gouveia, José A G Morais.   

Abstract

Drug distribution in blood, defined as drug blood-to-plasma concentration ratio (R(b)), is a fundamental pharmacokinetic parameter. It relates the plasma clearance to the blood clearance, enabling the physiological interpretation of this parameter. Although easily experimentally determined, R(b) values are lacking for the vast majority of drugs. We present a systematic approach using mechanistic, partial least squares (PLS) regression and artificial neural network (ANN) models to relate various in vitro and in silico molecular descriptors to a dataset of 93 drug R(b) values collected in the literature. The ANN model resulted in the best overall approach, with r(2)=0.927 and r(2)=0.871 for the train and the test sets, respectively. PLS regression presented r(2)=0.557 for the train and r(2)=0.656 for the test set. The mechanistic model provided the worst results, with r(2)=0.342 and, additionally, is limited to drugs with a basic ionised group with pKa<7. The ANN model for drug distribution in blood can be a valuable tool in clinical pharmacokinetics as well as in new drug design, providing predictions of R(b) with a percentage of correct values within a 1.25-fold error of 86%, 84% and 87% in the train, test and validation set of data.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19152835     DOI: 10.1016/j.ejps.2008.12.011

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  10 in total

1.  Development of a decision tree to classify the most accurate tissue-specific tissue to plasma partition coefficient algorithm for a given compound.

Authors:  Yejin Esther Yun; Cecilia A Cotton; Andrea N Edginton
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-11-21       Impact factor: 2.745

2.  Prediction of drug distribution in rat and humans using an artificial neural networks ensemble and a PBPK model.

Authors:  Paulo Paixão; Natália Aniceto; Luís F Gouveia; José A G Morais
Journal:  Pharm Res       Date:  2014-05-28       Impact factor: 4.200

3.  Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.

Authors:  Hannah Kinvig; Nicolas Cottura; Andrew Lloyd; Collrane Frivold; Jessica Mistilis; Courtney Jarrahian; Marco Siccardi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-09-30       Impact factor: 2.569

4.  Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo Approach.

Authors:  Floriane Lignet; Eva Sherbetjian; Nicole Kratochwil; Russell Jones; Claudia Suenderhauf; Michael B Otteneder; Thomas Singer; Neil Parrott
Journal:  Pharm Res       Date:  2016-07-28       Impact factor: 4.200

5.  Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.

Authors:  R K R Rajoli; A T Podany; D M Moss; S Swindells; C Flexner; A Owen; M Siccardi
Journal:  Int J Tuberc Lung Dis       Date:  2018-08-01       Impact factor: 2.373

6.  Multi-Well Array Culture of Primary Human Hepatocyte Spheroids for Clearance Extrapolation of Slowly Metabolized Compounds.

Authors:  Lena C Preiss; Volker M Lauschke; Katrin Georgi; Carl Petersson
Journal:  AAPS J       Date:  2022-03-11       Impact factor: 4.009

7.  Influence of cancer cachexia on drug liver metabolism and renal elimination in rats.

Authors:  Katja Cvan Trobec; Mojca Kerec Kos; Jurij Trontelj; Iztok Grabnar; Anika Tschirner; Sandra Palus; Stefan D Anker; Jochen Springer; Mitja Lainscak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-03       Impact factor: 12.910

8.  A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions.

Authors:  Mohammed H Cherkaoui-Rbati; Stuart W Paine; Peter Littlewood; Cyril Rauch
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

9.  Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.

Authors:  Marije Strikwold; Bert Spenkelink; Laura H J de Haan; Ruud A Woutersen; Ans Punt; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2016-11-04       Impact factor: 5.153

10.  Predicting blood-to-plasma concentration ratios of drugs from chemical structures and volumes of distribution in humans.

Authors:  Hideaki Mamada; Kazuhiko Iwamoto; Yukihiro Nomura; Yoshihiro Uesawa
Journal:  Mol Divers       Date:  2021-02-10       Impact factor: 3.364

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.